Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases

por Chen, Thomas C., Da Fonseca, Clovis O., Schönthal, Axel H.
Publicado 2016

Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development

por Chen, Thomas C., da Fonseca, Clovis O., Schönthal, Axel H.
Publicado 2018

The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers

por Chen, Thomas C., da Fonseca, Clovis O., Levin, Daniel, Schönthal, Axel H.
Publicado 2021

Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism

por Faria, Giselle M., Soares, Igor D. P., D’Alincourt Salazar, Marcela, Amorim, Marcia R., Pessoa, Bruno L., da Fonseca, Clovis O., Quirico-Santos, Thereza
Publicado 2020

Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy

por Santos, Juliana Guimaraes, Faria, Gisele, Cruz, Wanise Da Cruz Souza Da, Fontes, Cristina Asvolinsque, Schönthal, Axel H., Quirico-Santos, Thereza, da Fonseca, Clovis O.
Publicado 2020

Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma

por Schönthal, Axel H, Peereboom, David M, Wagle, Naveed, Lai, Rose, Mathew, Anna J, Hurth, Kyle M, Simmon, Vincent F, Howard, Steven P, Taylor, Lynne P, Chow, Frances, da Fonseca, Clovis O, Chen, Thomas C
Publicado 2021